Is There An Opportunity With MicroPort NeuroTech Limited's (HKG:2172) 43% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, MicroPort NeuroTech fair value estimate is HK$16.08 MicroPort NeuroTech's HK$9.15 share price signals that it might be 43% undervalued Ana
MicroPort Scientific Insiders Forfeit On 11% Gains After Selling Stock
Despite a 11% gain in MicroPort Scientific Corporation's (HKG:853) stock price this week, shareholders shouldn't let up. The fact that insiders chose to dispose of US$2.1m worth of stock in the past
Minimally Invasive Healthcare (00853): Cardiac Healthcare's net profit in the first quarter was about 184 million yuan, up 47.62% year-on-year
Minimally Invasive Healthcare (00853) announced the results of Cardiac Medical Technology for the first quarter of 2024, with revenue of about 358 million yuan, the same...
Is Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016) Worth CN¥178 Based On Its Intrinsic Value?
Key Insights Shanghai MicroPort Endovascular MedTech's estimated fair value is CN¥146 based on 2 Stage Free Cash Flow to Equity Current share price of CN¥178 suggests Shanghai MicroPort Endovascular
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) fell by more than 4% and recently received conditions from Gao Lin to relieve long-term debt problems, and it may still be difficult
Minimally Invasive Healthcare (00853) fell by more than 4%, and its stock price has fallen by more than 37% during the year. As of press release, it fell 4.17% to HK$5.28, with a turnover of HK$20.3597 million.
Microport Cardioflow Inks Services Deal With Subsidiary
Microport Cardioflow Medtech (HKG:2160) agreed to provide supporting services to its 51%-owned unit Shanghai MicroPort CardioAdvent for 2021, according to a Monday filing with the Hong Kong bourse. Th
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) falls more than 5% to ease short-term debt pressure, Nomura says the long-term debt problem is still difficult
Minimally Invasive Medicine (00853) fell by more than 5%. As of press release, it fell 4.84% to HK$5.5, with a turnover of HK$28.9347 million.
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) fell nearly 4% at the end of the session, and the company received US$150 million in convertible share financing Nomura says the long-term debt problem is still difficult
Minimally Invasive Healthcare (00853) fell nearly 4% at the end of the session. As of press release, it was down 3.92% to HK$6.12, with a turnover of HK$49.6016 million.
Debt concerns have been alleviated, and minimally invasive healthcare (00853) is expected to reach a turning point
Gao Lin Capital (former lender) agreed to provide term loan financing for minimally invasive medical care at a total capital of US$150 million, with an annual interest rate of 5.75%. At the same time, it also enjoyed the flexible option of further increasing the total principal amount of no more than 50 million US dollars.
[Broker Focus] Nomura cuts minimally invasive healthcare (00853) target price of 6.7% to HK$6.71, indicating that the long-term debt problem is still difficult
Jinwu Financial News | According to the Nomura Research Report, the management of Minimally Invasive Healthcare (00853) recently announced its plan to repay convertible bonds (CB), while providing guidance for the 2024-2026 fiscal year. The outstanding CB is about US$448 million, and the company issued a new CB of US$150 million to the management of Hillhouse Capital (Hillhouse Capital), the current convertible bondholder, at an annual interest rate of 5.75%; 2) US$300 million credit from financial institutions, and management believes that the interest rate will not be higher than 6%. The bank believes that the situation may improve in the short term, but it will still be difficult in the long run
Minimally Invasive Healthcare (00853) granted a total of 11.648,800 share options
Minimally Invasive Healthcare (00853) issued an announcement. The board of directors of Minimally Invasive Medical Science Co., Ltd. announced that the company announced on June 1, 2023...
MicroPort Scientific to Receive $150 Million Loan Facility, $300 Million Credit Support to Repay Convertible Bonds
MicroPort Scientific (HKG:0853) will receive a $150 million convertible term loan facility from four lenders with an interest rate of 5.75% per annum and falling due in 60 months, an April 5 filing on
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) raised more than 3%, and the company received a loan of US$150 million to be used to repay bonds
Minimally Invasive Medicine (00853) was more than 3% higher. As of press release, it rose 3.4% to HK$7, with a turnover of HK$4.949 million.
Minimally Invasive Healthcare (00853) received US$150 million convertible term loan financing
Zhitong Finance App News, Minimally Invasive Healthcare (00853) announced that in order to repay the outstanding amount of the 2026 convertible bond (about US$448 million), on April 5, 2024, the company signed a convertible financing agreement with the original lender. The original lender agreed to provide the company with a total principal amount of US$150 million and an annual interest rate of 5.75%. At the same time, the original lender also enjoyed a flexible option to further increase the total principal amount of no more than 50 million US dollars (if this option is fully exercised, the original lender's total loan principal amount will reach 2. billion dollars). If it is possible to refinance shares
Does MicroPort Scientific (HKG:853) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
MicroPort CardioFlow Medtech Corporation's (HKG:2160) Share Price Not Quite Adding Up
MicroPort CardioFlow Medtech Corporation's (HKG:2160) price-to-sales (or "P/S") ratio of 6.1x may look like a poor investment opportunity when you consider close to half the companies in the Medical E
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016) just reported some strong earnings, and the market reacted accordingly with a healthy uplift in the share price. However, we think that
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) fell more than 14%, and last year's loss increased 9.4% year on year to US$478 million
Minimally Invasive Medicine (00853) fell by more than 14%. As of press release, it was down 14% to HK$5.65, with a turnover of HK$97.901 million.
Shanghai MicroPort EP MedTech Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
As you might know, Shanghai MicroPort EP MedTech Co., Ltd. (SHSE:688351) last week released its latest full-year, and things did not turn out so great for shareholders. Results showed a clear ear
Analysts Have Made A Financial Statement On Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Annual Report
It's been a good week for Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016) shareholders, because the company has just released its latest yearly results, and the shares gained 3.7% to C
No Data